天灸联合益气通脉汤对脑梗死(气虚血瘀证)患者神经功能及c-反应蛋白的影响

Effect of Tianmoxibustion combined with Yiqi Tongmai Decoction on nerve function and C-reactive protein in patients with cerebral infarction (syndrome of Qi deficiency and blood stasis)

ES评分 0

DOI 10.12208/j.ircm.20240034
刊名
International Research in Chinese Medicine
年,卷(期) 2024, 4(2)
作者
作者单位

成都市双流区中医医院神经内科 四川成都 ;

摘要
分析天灸联合益气通脉汤对脑梗死(气虚血瘀证)患者神经功能及C-反应蛋白(CRP)的影响。方法 该研究总共纳入100例试验对象,均是2021年5月至2023年5月到医院诊治的脑梗死(气虚血瘀证)患者,利用随机数字表法进行分组,分为对照组(常规治疗,n=50)与试验组(天灸联合益气通脉汤治疗,n=50)。对比两组的神经功能、日常生活能力及炎症因子。结果 试验组较于对照组,其NIHSS评分、CRP及基质金属蛋白酶-9(MMP-9)更低,BI评分更高(P<0.05)。结论 天灸联合益气通脉汤用于脑梗死(气虚血瘀证)患者的治疗效果确切,有利于改善神经功能,减轻炎症反应。
Abstract
Objective To analyze the effects of Tianmoxibustion combined with Yiqitongmai Decoction on nerve function and C-reactive protein (CRP) in patients with cerebral infarction (syndrome of Qi deficiency and blood stasis). Methods A total of 100 subjects were included in this study, all patients with cerebral infarction (qi deficiency and blood stasis syndrome) who were treated in hospital from May 2021.05 to May 2023.05. They were divided into control group (conventional treatment, n=50) and experimental group (Tianmoxibustion combined Yiqi Tongmai Decoction treatment, n=50) by random number table method. Neurological function, daily living ability and inflammatory factors were compared between the two groups. Results Compared with control group, NIHSS score, CRP and matrix metalloproteinase-9 (MMP-9) in experimental group were lower, BI score was higher (P < 0.05). Conclusion Tianmoxibustion combined Yiqitongmai Decoction is effective in the treatment of patients with cerebral infarction (qi deficiency and blood stasis syndrome), which is conducive to improving nerve function and reducing inflammation.
关键词
脑梗死(气虚血瘀证);天灸;益气通脉汤;神经功能
KeyWord
Cerebral infarction (Qi deficiency and blood stasis syndrome); Natural moxibustion; Yiqi Tongpulse decoction; Neural function
基金项目
页码 40-42
  • 参考文献
  • 相关文献
  • 引用本文

王志平*,钟丽,沈龙. 天灸联合益气通脉汤对脑梗死(气虚血瘀证)患者神经功能及c-反应蛋白的影响 [J]. 国际中医药研究. 2024; 4; (2). 40 - 42.

  • 文献评论

相关学者

相关机构